Adaptation of the Guidance document Orphan Drug HMV4

09.04.2019

Correction, supplement an explanation in chapter 5 (Fees), 6.4 (ODS and indication extensions) and 6.8 (Transfer of status)

The new version of the affected document enter into force as of 09.04.2019.